Logo image
Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness
Journal article   Open access   Peer reviewed

Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness

Meeta Yadav, Soham Ali, Rachel L Shrode, Shailesh K Shahi, Samantha N Jensen, Jemmie Hoang, Samuel Cassidy, Heena Olalde, Natalya Guseva, Mishelle Paullus, …
PloS one, Vol.17(4), p.e0264556
04/01/2022
DOI: 10.1371/journal.pone.0264556
PMCID: PMC9041819
PMID: 35472144
url
https://doi.org/10.1371/journal.pone.0264556View
Published (Version of record) Open Access

Abstract

Trillions of microbes such as bacteria, fungi, and viruses exist in the healthy human gut microbiome. Although gut bacterial dysbiosis has been extensively studied in multiple sclerosis (MS), the significance of the fungal microbiome (mycobiome) is an understudied and neglected part of the intestinal microbiome in MS. The aim of this study was to characterize the gut mycobiome of patients with relapsing-remitting multiple sclerosis (RRMS), compare it to healthy controls, and examine its association with changes in the bacterial microbiome. We characterized and compared the mycobiome of 20 RRMS patients and 33 healthy controls (HC) using Internal Transcribed Spacer 2 (ITS2) and compared mycobiome interactions with the bacterial microbiome using 16S rRNA sequencing. Our results demonstrate an altered mycobiome in RRMS patients compared with HC. RRMS patients showed an increased abundance of Basidiomycota and decreased Ascomycota at the phylum level with an increased abundance of Candida and Epicoccum genera along with a decreased abundance of Saccharomyces compared to HC. We also observed an increased ITS2/16S ratio, altered fungal and bacterial associations, and altered fungal functional profiles in MS patients compared to HC. This study demonstrates that RRMS patients had a distinct mycobiome with associated changes in the bacterial microbiome compared to HC. There is an increased fungal to bacterial ratio as well as more diverse fungal-bacterial interactions in RRMS patients compared to HC. Our study is the first step towards future studies in delineating the mechanisms through which the fungal microbiome can influence MS disease.
Antibiotics Bacteria Digestive System Disease Gastrointestinal Surgery Health Care Immunology Informatics Multiple Sclerosis Neurology Pathogenesis Pathology Software Abundance Autoimmune diseases Digestive tract Dysbacteriosis Fungi Hospitals Interdisciplinary aspects Intestinal microflora Laboratories Medical schools Medicine Microbiomes Microbiota Neutrophils Patients rRNA 16S Viruses

Details

Metrics

Logo image